How is neuropathic cancer pain assessed in randomised controlled trials?

被引：5

作者：

Kurita, Geana Paula ^{[1
,2
,3
]}

Ulrich, Angelika ^{[4
]}

Jensen, Troels Staehelin ^{[5
]}

Werner, Mads Utke ^{[2
]}

Sjogren, Per ^{[1
]}

机构：

[1] Rigshosp, Sect Acute Pain Management & Palliat Med, DK-2100 Copenhagen, Denmark

[2] Rigshosp, Ctr Multidisciplinary Pain, DK-2100 Copenhagen, Denmark

[3] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil

[4] Vejle Cty Hosp SLB, Pain Clin, Vejle, Denmark

[5] Aarhus Univ Hosp, Pain Res Ctr, DK-8000 Aarhus, Denmark

来源：

PAIN | 2012年 / 153卷 / 01期

关键词：

DOUBLE-BLIND; INTRAVENOUS LIDOCAINE; MORPHINE THERAPY; EFNS GUIDELINES; GABAPENTIN; VALIDATION; MANAGEMENT; CROSSOVER; SYSTEM; SCALE;

D O I：

10.1016/j.pain.2011.08.013

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：13 / 17

页数：5

共 31 条

[1] Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine [J].

Arai, Young-Chang P. ;

Matsubara, Takako ;

Shimo, Kazuhiro ;

Suetomi, Katsutoshi ;

Nishihara, Makoto ;

Ushida, Takahiro ;

Kobayashi, Kunio ;

Suzuki, Chiharu ;

Kinoshita, Akiko ;

Kondo, Miki ;

Matsubara, Satuki ;

Hayashi, Ruiko ;

Tohyama, Yukio ;

Nishida, Kikuyo ;

Arakawa, Maki .

JOURNAL OF ANESTHESIA, 2010, 24 (03) :407-410

[2] Tramadol in the treatment of neuropathic cancer pain - A double-blind, placebo-controlled study [J].

Arbaiza, Daniel ;

Vidal, Oscar .

CLINICAL DRUG INVESTIGATION, 2007, 27 (01) :75-83

[3] EFNS guidelines on pharmacological treatment of neuropathic pain [J].

Attal, N. ;

Cruccu, G. ;

Haanpaa, M. ;

Hansson, P. ;

Jensen, T. S. ;

Nurmikko, T. ;

Sampaio, C. ;

Sindrup, S. ;

Wiffen, P. .

EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (11) :1153-1169

[4] A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms [J].

Baron, Ralf ;

Toelle, Thomas R. ;

Gockel, Ulrich ;

Brosz, Mathias ;

Freynhagen, Rainer .

PAIN, 2009, 146 (1-2) :34-40

[5] The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs [J].

Bennett, M .

PAIN, 2001, 92 (1-2) :147-157

[6] Development and validation of the neuropathic pain symptom inventory [J].

Bouhassira, D ;

Attal, N ;

Fermanian, J ;

Alchaar, H ;

Gautron, M ;

Masquelier, E ;

Rostaing, S ;

Lanteri-Minet, M ;

Collin, E ;

Grisart, J ;

Boureau, F .

PAIN, 2004, 108 (03) :248-257

[7] A PROSPECTIVE MULTICENTER ASSESSMENT OF THE EDMONTON STAGING SYSTEM FOR CANCER PAIN [J].

BRUERA, E ;

SCHOELLER, T ;

WENK, R ;

MACEACHERN, T ;

MARCELINO, S ;

HANSON, J ;

SUAREZALMAZOR, M .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (05) :348-355

[8] A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF INTRAVENOUS LIDOCAINE IN THE TREATMENT OF NEUROPATHIC CANCER PAIN [J].

BRUERA, E ;

RIPAMONTI, C ;

BRENNEIS, C ;

MACMILLAN, K ;

HANSON, J .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (03) :138-140

[9] Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group [J].

Caraceni, A ;

Zecca, E ;

Bonezzi, C ;

Arcuri, E ;

Tur, RY ;

Maltoni, M ;

Visentin, M ;

Gorni, G ;

Martini, C ;

Tirelli, W ;

Barbieri, M ;

De Conno, F .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2909-2917

[10] An international survey of cancer pain characteristics and syndromes [J].

Caraceni, A ;

Portenoy, RK .

PAIN, 1999, 82 (03) :263-274

← 1 2 3 4 →